戻る Agenda
S36 : Promoting a "Clinical Trial Ecosystem" as ALL Japan
Session Chair(s)
Keiichi Inaizumi, MSc
Clinical Study Innovation Lead, Clinical Project Management Group, Pfizer R&D Japan, Japan
Speaker(s)
Yoichi Yamamoto, MD, PhD
Academic Clinical Research Center, Department of Medical Innovation/ Professor, Osaka University Hospital, Japan
Shin Nishikawa
TF2-5, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Toshimichi Naito
Director, Clinical Enablement, Clinical Operations, Japan Development, MSD K.K. / R&D Head Club, Japan
Katsuaki Ura
Deputy Director, Office of International Regulatory Affairs, Ministry of Health, Labour and Welfare (MHLW), Japan